{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:25:13Z","timestamp":1794349513376,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM202311025"],"award-info":[{"award-number":["SZSM202311025"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471555"],"award-info":[{"award-number":["82471555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201693"],"award-info":[{"award-number":["82201693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eclinm.2025.103626","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T06:00:11Z","timestamp":1762581611000},"page":"103626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy and safety of perospirone as adjunctive therapy in major depressive disorder patients with inadequate response to antidepressants: a randomized clinical trial"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-1985","authenticated-orcid":false,"given":"Jin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanfang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-3820","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103626_bib1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001403","article-title":"Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes","volume":"10","author":"Spielmans","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2025.103626_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12888-025-06783-7","article-title":"The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis","volume":"25","author":"Bai","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/bdi.13035","article-title":"The 2020 royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.eclinm.2025.103626_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"10.1016\/j.eclinm.2025.103626_bib6","article-title":"Trajectories of acute antidepressant efficacy: how long to wait for response? A systematic review and meta-analysis of long-term, placebo-controlled acute treatment trials","volume":"79","author":"Henssler","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib7","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1176\/ajp.152.10.1500","article-title":"Early nonresponse to fluoxetine as a predictor of poor 8-week outcome","volume":"152","author":"Nierenberg","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ijnp\/pyx081","article-title":"Functional recovery in major depressive disorder: providing early optimal treatment for the individual patient","volume":"21","author":"Oluboka","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.eclinm.2025.103626_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/0004867420968912","article-title":"Changes in antidepressant therapy should be considered early in patients with inadequate response to a first-line agent","volume":"55","author":"Baune","year":"2021","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jad.2008.10.011","article-title":"Does early improvement triggered by antidepressants predict response\/remission? \u2014 analysis of data from a naturalistic study on a large sample of inpatients with major depression","volume":"115","author":"Henkel","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2025.103626_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hup.1019","article-title":"How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database","volume":"24","author":"Baldwin","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.eclinm.2025.103626_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40263-014-0171-5","article-title":"Early switching strategies in antidepressant non-responders: current evidence and future research directions","volume":"28","author":"Kudlow","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eclinm.2025.103626_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000332050","article-title":"A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A study)","volume":"81","author":"Fava","year":"2012","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.eclinm.2025.103626_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.eclinm.2025.103626_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4088\/JCP.14m09689","article-title":"Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study","volume":"76","author":"Thase","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2015.14101251","article-title":"Ziprasidone augmentation of escitalopram for major depressive disorder: efficacy results from a randomized, double-blind, placebo-controlled study","volume":"172","author":"Papakostas","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1254\/jjp.54.478","article-title":"Binding profile of SM-9018, a novel antipsychotic candidate","volume":"54","author":"Kato","year":"1990","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.eclinm.2025.103626_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00023210-200115040-00006","article-title":"Perospirone","volume":"15","author":"Onrust","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eclinm.2025.103626_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1440-1819.2011.02191.x","article-title":"Mirtazapine in combination with perospirone synergistically enhances dopamine release in the rat prefrontal cortex via 5-HT1A receptor activation","volume":"65","author":"Morita","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.eclinm.2025.103626_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2004.03.079","article-title":"Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex","volume":"364","author":"Yoshino","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.eclinm.2025.103626_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pnpbp.2006.10.014","article-title":"Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression","volume":"31","author":"Otsuka","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.pnpbp.2008.12.018","article-title":"Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder","volume":"33","author":"Sato","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40263-013-0085-7","article-title":"Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Kishi","year":"2013","journal-title":"CNS Drugs"},{"issue":"Suppl 20","key":"10.1016\/j.eclinm.2025.103626_bib24","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib25","first-page":"3","article-title":"Development of new treatments for depression","volume":"46","author":"Montgomery","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the common terminology criteria for adverse events (CTCAE\u2013Version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.eclinm.2025.103626_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/02698811221104058","article-title":"Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression","volume":"37","author":"Scott","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.eclinm.2025.103626_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1092852900020216","article-title":"Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants","volume":"14","author":"Berman","year":"2009","journal-title":"CNS Spectr"},{"key":"10.1016\/j.eclinm.2025.103626_bib30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib31","article-title":"Functional recovery in major depressive disorder: focus on early optimized treatment","volume":"18","author":"Habert","year":"2016","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.eclinm.2025.103626_bib32","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1017\/S1092852925000276","article-title":"Urgency to treat and early optimized treatment in major depressive disorder: consequences of delayed treatment, barriers to implementation, and practical strategies for clinicians","volume":"30","author":"Oluboka","year":"2025","journal-title":"CNS Spectr"},{"key":"10.1016\/j.eclinm.2025.103626_bib33","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2025.103626_bib34","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.4088\/JCP.11r07485","article-title":"Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis","volume":"73","author":"Iovieno","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib35","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/brain\/awae132","article-title":"How side effects can improve treatment efficacy: a randomized trial","volume":"147","author":"Schenk","year":"2024","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.eclinm.2025.103626_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamapsychiatry.2025.0085","article-title":"Expectancy effects, failure of blinding integrity, and placebo response in trials of treatments for psychiatric disorders: a narrative review","volume":"82","author":"Huneke","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jad.2021.09.025","article-title":"Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder","volume":"296","author":"Sumiyoshi","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2025.103626_bib39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0091-3057(98)00068-9","article-title":"Anxiolytic-like effects of perospirone, a novel serotonin-2 and dopamine-2 antagonist (SDA)-type antipsychotic agent","volume":"60","author":"Sakamoto","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.eclinm.2025.103626_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1254\/jjp.72.119","article-title":"Evaluation of perospirone (SM-9018), a novel serotonin-2 and dopamine-2 receptor antagonist, and other antipsychotics in the conditioned fear stress-induced freezing behavior model in rats","volume":"72","author":"Ishida-Tokuda","year":"1996","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.eclinm.2025.103626_bib41","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1440-1819.2005.01427.x","article-title":"Perospirone for treatment of dissociative identity disorder","volume":"59","author":"Okugawa","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.eclinm.2025.103626_bib42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pnpbp.2006.06.021","article-title":"Perospirone in treatment of Huntington's disease: a first case report","volume":"31","author":"Roppongi","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103626_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/416396a","article-title":"Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult","volume":"416","author":"Gross","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2025.103626_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40263-014-0162-6","article-title":"Role of atypical antipsychotics in the treatment of generalized anxiety disorder","volume":"28","author":"Hershenberg","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eclinm.2025.103626_bib47","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3390\/cells11193035","article-title":"Presynaptic 5-HT2A-mGlu2\/3 receptor-receptor crosstalk in the prefrontal cortex: metamodulation of glutamate exocytosis","volume":"11","author":"Taddeucci","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.eclinm.2025.103626_bib48","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1123432","article-title":"Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice","volume":"313","author":"Weisstaub","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2025.103626_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-pharmtox-022723-112425","article-title":"The nocebo effect","volume":"64","author":"Colloca","year":"2024","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.eclinm.2025.103626_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024537","article-title":"Analysis and reporting of adverse events in randomised controlled trials: a review","volume":"9","author":"Phillips","year":"2019","journal-title":"BMJ Open"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:35:39Z","timestamp":1794346539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025005607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S2589537025005607"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103626","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of perospirone as adjunctive therapy in major depressive disorder patients with inadequate response to antidepressants: a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103626"}}